Model 4063 Dedicated Tray Sealer
Inspire Medical Systems · Decision date Nov 5, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-11-05 for PMA supplement P130008/S148, submitted by Inspire Medical Systems as a 30-Day Notice under the process change category covering manufacturer, sterilizer, packager or supplier. The supplement concerns the Model 4063 Dedicated Tray Sealer and associated outer tray sealing nest equipment used to manufacture the Model 4063 Stimulation Lead. The device category is an implanted hypoglossal nerve stimulator for apnea, listed under the anesthesiology specialty with product code MNQ.
The recorded scope is installation of that sealing equipment for lead manufacture, not a new approval of the underlying system. The source lists no supporting documents, so the review basis and any conditions of the decision remain unknown. Whether the change affects sterility assurance, lead performance or labeling is not stated in the available record, and no clinical or legal conclusion follows from the decision code alone.
FDA approval order statement
approval for the installation of a new Tray Sealer and associated outer tray sealing nest equipment used for the manufacture of the Model 4063 Stimulation Lead
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Anesthesiology
- Decision date
- Nov 5, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P130008/S148
- Regulatory pathway
- PMA supplement
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- Decision code
- OK30
- Decision date
- Nov 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P130008. Subsequent supplements may change the device or its indications.
FDA decision timeline
P130008 · Original PMA
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S148 received
Application receipt date recorded by FDA.
P130008/S146 · Related supplement
Model 3150 IPG
P130008/S147 · Related supplement
Model 3150 IPG
P130008/S144 · Related supplement
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S148 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P130008
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Inspire Medical Systems | PMA approval | Apr 30, 2014 | FDA | |
Model 3150 IPGP130008/S146 | Inspire Medical Systems | PMA supplement | Oct 13, 2026 | FDA |
Model 3150 IPGP130008/S147 | Inspire Medical Systems | PMA supplement | Oct 22, 2026 | FDA |
INSPIRE II UPPER AIRWAY STIMULATORP130008/S144 | Inspire Medical Systems | PMA supplement | Oct 26, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Inspire Medical Systems
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369
Sources and methodology
- Original FDA record: P130008/S148
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


